High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
Rachel Sacks‐Davis(Burnet Institute), Margaret Hellard(The Alfred Hospital), Usha K. Nivarthi(University of North Carolina at Chapel Hill), Campbell Aitken(Burnet Institute), Peter Higgs(Curtin University), Jason Grebely(UNSW Sydney), Vijayaprakash Suppiah(University of South Australia), Alisa Pedrana(Burnet Institute), Jacob George(University of Dundee), Scott Bowden(Victorian Infectious Diseases Reference Laboratory), Tim Spelman(Peter Doherty Institute), Mandvi Bharadwaj(The University of Melbourne), Heidi E. Drummer(The University of Melbourne)
Cited by 69
Related Papers
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
|The Lancet|2016|648
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
|Hepatology|2013|393
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
|Clinical Infectious Diseases|2009|234